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Abstract
A paradox is posed by metazoan gene-regulatory networks (GRNs) that are robust yet evolvable. Insight
may be obtained through studies of bistable genetic circuits mediating developmental decisions. A model in
organogenesis is provided by the sex-specific differentiation of the embryonic gonadal ridge to form a testis
or ovary. Here, we investigated a Swyer mutation in human testis-determining factor SRY that impairs its
phosphorylation in association with variable developmental outcomes: fertile male, intersex, or infertile
female (46, XY pure gonadal dysgenesis). The mutation (R30I) abrogates serine phosphorylation within a
putative target site for protein kinase A (PKA) N-terminal to the HMG box. Diverse processes can be
regulated by protein phosphorylation, including DNA recognition by transcription factors (TFs).
Phosphorylation of this site in human SRY (LRRSSSFLCT; italics) in vitro was previously shown to
enhance specific DNA affinity. Biological consequences of the mutation were evaluated in SRY-responsive
mammalian cell lines following transient transfection. The mutation attenuated in concert occupancy of a
target enhancer (TESCO) and SOX9 transcriptional activation. These perturbations were mitigated by acidic
substitution (LRIDDDFL) whereas Ala substitutions (RRAAAFL or RIAAAFL) attenuated activity to an
extent similar to R30I alone. No differences were observed in nuclear localization. Mutagenesis suggested
that the central Ser is most efficiently phosphorylated in accord with PKA targeting rules. Replacement of
the native site by an optimized “Kemptide” PKA site (LRRASLGCT) enhanced both SRY phosphorylation
and SOX9 transcriptional activation whereas a “swapped” protein-kinase C determinant (LRRSSFRRCT)
blocked phosphorylation. Among SRY variants, extent of cellular phosphorylation mirrored relative in vitro
efficiencies of synthetic SRY-derived peptides as PKA-specific substrates. Although several kinases are
predicted in silico to target this tri-serine motif, cell-based studies implicate PKA as the relevant kinase in
vivo. Our results provide evidence that primate Sry requires its phosphorylation for full gene-regulatory
activity. A PKA site N-terminal to the SRY HMG box, unique to primates, exemplifies network “tinkering”
through recruitment of a new regulatory linkage. Molecular characterization of the R30I inherited Swyer
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mutation in SRY thus demonstrates that impaired TF phosphorylation can attenuate a human developmental
switch at the edge of ambiguity.
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